SS-31 and MOTS-C get lumped together constantly because both target mitochondria, and both show up in the same “longevity peptide” conversations. But treating them as interchangeable misses the point entirely. One is a structural fix. The other is a signaling update. Understanding that difference matters for anyone actually trying to make sense of the research. […]
Aging research has converged on a handful of biological processes that show up again and again as the cell ages: mitochondria lose efficiency, telomeres shorten, and cells become more prone to dying off entirely. A small group of research peptides has emerged around these specific mechanisms, each targeting a different piece of the aging puzzle […]
Epithalon approaches the biology of aging from an angle almost no other research peptide touches directly: telomeres. While most longevity-focused peptides work on metabolic or mitochondrial pathways, Epithalon’s primary research interest centers on telomerase, the enzyme responsible for maintaining the protective caps on the ends of chromosomes that shorten every time a cell divides. This […]
SS-31, formally known as Elamipretide, is one of the few research peptides that doesn’t work through a receptor at all. While most peptides bind a cell-surface receptor and trigger a signaling cascade several steps removed from their actual chemistry, SS-31 crosses directly into the mitochondria and physically binds a specific membrane lipid. That distinction is […]